history of glp-1 drugs Another milestone in the evolution GLP-1-based diabetes therapies Upgrading from Overweight: The Effects
Description
Expert Opinion on Pharmacotherapy
10.1053/j.gastro.2011.02.018 [DOI] [PMC free article] [PubMed] [Google Scholar] 39.Butler A, Campbell-Thompson M, Gurlo T, Dawson D, Atkinson M, Butler P
Godfrey, H., Leibovit-Reiben, Z., et al
Understanding these differences requires examining what glucagon and GIP actually do in the body, how their activation complements GLP-1 signaling, and why dual agonism produces superior results compared to single GLP-1 agonists
Eur J Pharm Sci
doi: 10.1007/s00125-022-05722-5 [DOI] [PubMed] [Google Scholar] 25
